1 Attractive Pharma Stock You Probably Haven't Heard Of
December will mark the one-year anniversary for the initial listing of American depositary shares on the New York Stock Exchange by Takeda Pharmaceutical (NYSE: TAK). Many U.S. investors are unfamiliar with the name, likely due to its relatively recent listing on a major U.S. exchange.
Founded in Japan over 230 years ago, Takeda makes and sells drugs around the globe. Roughly 86% of its 50,000 employees work outside of Japan. Its most well-known products in the U.S. are diabetes drug Actos, Prevacid for heartburn and ulcers, and Adderall XR and Vyvanse, which treat attention deficit hyperactivity disorder and certain eating and sleeping disorders. Takeda's key business areas are rare diseases, neuroscience, oncology, gastrointestinal diseases, and plasma-derived therapies.
Image source: Getty Images.
Source Fool.com
